Copyright Reports & Markets. All rights reserved.

Global Prostacyclin Market Insights, Forecast to 2025

Buy now

1 Study Coverage

  • 1.1 Prostacyclin Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Prostacyclin Market Size Growth Rate by Type
    • 1.2.2 Epoprostenol Sodium
    • 1.2.3 Treprostinil
    • 1.2.4 Iloprost
    • 1.2.5 Beraprost Sodium
  • 1.3 Market by Application
    • 1.3.1 Global Prostacyclin Market Size Growth Rate by Application
    • 1.3.2 For Injection
    • 1.3.3 For Oral
    • 1.3.4 For Inhalation
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Prostacyclin Market Size Estimates and Forecasts
    • 2.1.1 Global Prostacyclin Revenue 2015-2026
    • 2.1.2 Global Prostacyclin Sales 2015-2026
  • 2.2 Prostacyclin Market Size by Region: 2020 Versus 2026
  • 2.3 Prostacyclin Sales by Region (2015-2026)
    • 2.3.1 Global Prostacyclin Sales by Region: 2015-2020
    • 2.3.2 Global Prostacyclin Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Prostacyclin Sales Market Share by Region (2015-2026)
  • 2.4 Prostacyclin Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Prostacyclin Revenue by Region: 2015-2020
    • 2.4.2 Global Prostacyclin Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Prostacyclin Revenue Market Share by Region (2015-2026)

3 Global Prostacyclin by Manufacturers

  • 3.1 Global Top Prostacyclin Manufacturers by Sales
    • 3.1.1 Global Prostacyclin Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Prostacyclin Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Prostacyclin Manufacturers by Revenue
    • 3.2.1 Global Prostacyclin Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Prostacyclin Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Prostacyclin Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Prostacyclin Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Prostacyclin Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Prostacyclin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Prostacyclin Manufacturing Base Distribution, Product Type
    • 3.5.1 Prostacyclin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Prostacyclin Product Type
    • 3.5.3 Date of International Manufacturers Enter into Prostacyclin Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 United Therapeutics
    • 4.1.1 United Therapeutics Corporation Information
    • 4.1.2 United Therapeutics Description, Business Overview
    • 4.1.3 United Therapeutics Prostacyclin Products Offered
    • 4.1.4 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 United Therapeutics Prostacyclin Revenue by Product
    • 4.1.6 United Therapeutics Prostacyclin Revenue by Application
    • 4.1.7 United Therapeutics Prostacyclin Revenue by Geographic Area
    • 4.1.8 United Therapeutics Prostacyclin Revenue by Sales Channel
    • 4.1.9 United Therapeutics Recent Development
  • 4.2 Actelion (J & J)
    • 4.2.1 Actelion (J & J) Corporation Information
    • 4.2.2 Actelion (J & J) Description, Business Overview
    • 4.2.3 Actelion (J & J) Prostacyclin Products Offered
    • 4.2.4 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 Actelion (J & J) Prostacyclin Revenue by Product
    • 4.2.6 Actelion (J & J) Prostacyclin Revenue by Application
    • 4.2.7 Actelion (J & J) Prostacyclin Revenue by Geographic Area
    • 4.2.8 Actelion (J & J) Prostacyclin Revenue by Sales Channel
    • 4.2.9 Actelion (J & J) Recent Development
  • 4.3 GSK
    • 4.3.1 GSK Corporation Information
    • 4.3.2 GSK Description, Business Overview
    • 4.3.3 GSK Prostacyclin Products Offered
    • 4.3.4 GSK Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 GSK Prostacyclin Revenue by Product
    • 4.3.6 GSK Prostacyclin Revenue by Application
    • 4.3.7 GSK Prostacyclin Revenue by Geographic Area
    • 4.3.8 GSK Prostacyclin Revenue by Sales Channel
    • 4.3.9 GSK Recent Development
  • 4.4 Teva
    • 4.4.1 Teva Corporation Information
    • 4.4.2 Teva Description, Business Overview
    • 4.4.3 Teva Prostacyclin Products Offered
    • 4.4.4 Teva Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Teva Prostacyclin Revenue by Product
    • 4.4.6 Teva Prostacyclin Revenue by Application
    • 4.4.7 Teva Prostacyclin Revenue by Geographic Area
    • 4.4.8 Teva Prostacyclin Revenue by Sales Channel
    • 4.4.9 Teva Recent Development
  • 4.5 Toray
    • 4.5.1 Toray Corporation Information
    • 4.5.2 Toray Description, Business Overview
    • 4.5.3 Toray Prostacyclin Products Offered
    • 4.5.4 Toray Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 Toray Prostacyclin Revenue by Product
    • 4.5.6 Toray Prostacyclin Revenue by Application
    • 4.5.7 Toray Prostacyclin Revenue by Geographic Area
    • 4.5.8 Toray Prostacyclin Revenue by Sales Channel
    • 4.5.9 Toray Recent Development
  • 4.6 Tide Pharma
    • 4.6.1 Tide Pharma Corporation Information
    • 4.6.2 Tide Pharma Description, Business Overview
    • 4.6.3 Tide Pharma Prostacyclin Products Offered
    • 4.6.4 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 Tide Pharma Prostacyclin Revenue by Product
    • 4.6.6 Tide Pharma Prostacyclin Revenue by Application
    • 4.6.7 Tide Pharma Prostacyclin Revenue by Geographic Area
    • 4.6.8 Tide Pharma Recent Development
  • 4.7 Bayer AG
    • 4.7.1 Bayer AG Corporation Information
    • 4.7.2 Bayer AG Description, Business Overview
    • 4.7.3 Bayer AG Prostacyclin Products Offered
    • 4.7.4 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 Bayer AG Prostacyclin Revenue by Product
    • 4.7.6 Bayer AG Prostacyclin Revenue by Application
    • 4.7.7 Bayer AG Prostacyclin Revenue by Geographic Area
    • 4.7.8 Bayer AG Recent Development

...

    5 Breakdown Data by Type

    • 5.1 Global Prostacyclin Sales by Type (2015-2026)
      • 5.1.1 Global Prostacyclin Sales by Type (2015-2020)
      • 5.1.2 Global Prostacyclin Sales Forecast by Type (2021-2026)
      • 5.1.3 Global Prostacyclin Sales Market Share by Type (2015-2026)
    • 5.2 Global Prostacyclin Revenue Forecast by Type (2015-2026)
      • 5.2.1 Global Prostacyclin Revenue by Type (2015-2020)
      • 5.2.2 Global Prostacyclin Revenue Forecast by Type (2021-2026)
      • 5.2.3 Global Prostacyclin Revenue Market Share by Type (2015-2026)
    • 5.3 Prostacyclin Average Selling Price (ASP) by Type (2015-2026)

    6 Breakdown Data by Application

    • 6.1 Global Prostacyclin Sales by Application (2015-2026)
      • 6.1.1 Global Prostacyclin Sales by Application (2015-2020)
      • 6.1.2 Global Prostacyclin Sales Forecast by Application (2021-2026)
      • 6.1.3 Global Prostacyclin Sales Market Share by Application (2015-2026)
    • 6.2 Global Prostacyclin Revenue Forecast by Application (2015-2026)
      • 6.2.1 Global Prostacyclin Revenue by Application (2015-2020)
      • 6.2.2 Global Prostacyclin Revenue Forecast by Application (2021-2026)
      • 6.2.3 Global Prostacyclin Revenue Market Share by Application (2015-2026)
    • 6.3 Prostacyclin Average Selling Price (ASP) by Application (2015-2026)

    7 North America

    • 7.1 North America Prostacyclin Market Size YoY Growth 2015-2026
    • 7.2 North America Prostacyclin Market Facts & Figures by Country
      • 7.2.1 North America Prostacyclin Sales by Country (2015-2026)
      • 7.2.2 North America Prostacyclin Revenue by Country (2015-2026)
    • 7.3 North America Prostacyclin Sales by Type
    • 7.4 North America Prostacyclin Sales by Application

    8 Asia-Pacific

    • 8.1 Asia-Pacific Prostacyclin Market Size YoY Growth 2015-2026
    • 8.2 Asia-Pacific Prostacyclin Market Facts & Figures by Region
      • 8.2.1 Asia-Pacific Prostacyclin Sales by Region (2015-2026)
      • 8.2.2 Asia-Pacific Prostacyclin Revenue by Region (2015-2026)
    • 8.3 Asia-Pacific Prostacyclin Sales by Type
    • 8.4 Asia-Pacific Prostacyclin Sales by Application

    9 Europe

    • 9.1 Europe Prostacyclin Market Size YoY Growth 2015-2026
    • 9.2 Europe Prostacyclin Market Facts & Figures by Country
      • 9.2.1 Europe Prostacyclin Sales by Country (2015-2026)
      • 9.2.2 Europe Prostacyclin Revenue by Country (2015-2026)
    • 9.3 Europe Prostacyclin Sales by Type
    • 9.4 Europe Prostacyclin Sales by Application

    10 Latin America

    • 10.1 Latin America Prostacyclin Market Size YoY Growth 2015-2026
    • 10.2 Latin America Prostacyclin Market Facts & Figures by Country
      • 10.2.1 Latin America Prostacyclin Sales by Country (2015-2026)
      • 10.2.2 Latin America Prostacyclin Revenue by Country (2015-2026)
    • 10.3 Latin America Prostacyclin Sales by Type
    • 10.4 Latin America Prostacyclin Sales by Application

    11 Middle East and Africa

    • 11.1 Middle East and Africa Prostacyclin Market Size YoY Growth 2015-2026
    • 11.2 Middle East and Africa Prostacyclin Market Facts & Figures by Country
      • 11.2.1 Middle East and Africa Prostacyclin Sales by Country (2015-2026)
      • 11.2.2 Middle East and Africa Prostacyclin Revenue by Country (2015-2026)
    • 11.3 Middle East and Africa Prostacyclin Sales by Type
    • 11.4 Middle East and Africa Prostacyclin Sales by Application

    12 Supply Chain and Sales Channel Analysis

    • 12.1 Prostacyclin Supply Chain Analysis
    • 12.2 Prostacyclin Key Raw Materials and Upstream Suppliers
    • 12.3 Prostacyclin Clients Analysis
    • 12.4 Prostacyclin Sales Channel and Sales Model Analysis
      • 12.4.1 Prostacyclin Distribution Channel Analysis: Indirect Sales VS Direct Sales
      • 12.4.2 Prostacyclin Distribution Channel Analysis: Online Sales VS Offline Sales
      • 12.4.3 Prostacyclin Distributors

    13 Market Dynamics

    • 13.1 Prostacyclin Market Drivers
    • 13.2 Prostacyclin Market Opportunities
    • 13.3 Prostacyclin Market Challenges
    • 13.4 Prostacyclin Market Restraints
    • 13.5 Porter’s Five Forces Analysis

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Prostacyclin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Prostacyclin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

      Segment by Type, the Prostacyclin market is segmented into
      Epoprostenol Sodium
      Treprostinil
      Iloprost
      Beraprost Sodium

      Segment by Application, the Prostacyclin market is segmented into
      For Injection
      For Oral
      For Inhalation

      Regional and Country-level Analysis:
      North America
      United States
      Canada
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Southeast Asia
      Australia
      Rest of Asia-Pacific
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Nordic Countries
      Rest of Europe
      Latin America
      Mexico
      Brazil
      Rest of Latin America
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of MEA

      Competitive Landscape and Prostacyclin Market Share Analysis
      Prostacyclin market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Prostacyclin product introduction, recent developments, Prostacyclin sales by region, type, application and by sales channel.

      The major companies include:
      United Therapeutics
      Actelion (J & J)
      GSK
      Teva
      Toray
      Tide Pharma
      Bayer AG
      ...

      Buy now